PCAP:NASDAQProCap Acquisition Corp Analysis
Data as of 2026-07-23 - not real-time
$10.31
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ProCap Acquisition Corp is trading at $10.31, hugging its recent resistance level of $10.31 while just above the identified support of $10.26. Technical momentum remains bullish with the 20‑day SMA ($10.29) and 50‑day SMA ($10.28) both under the current price, and the 200‑day SMA ($10.23) also below, indicating an uptrend. The RSI sits at 64, suggesting strength but still below overbought territory, whereas the MACD shows a subtle bearish divergence (histogram –0.00028) that could hint at short‑term weakness. Volume is on a decreasing trend, and daily turnover (7,095 shares) is far below the 10‑day average (~117k), raising liquidity concerns. The stock’s beta is virtually zero (0.02) and 30‑day volatility is modest (1.4%), reflecting a very low market‑risk profile. However, valuation metrics are stretched: a trailing PE of 32 versus an industry average of 18, and a negative price‑to‑book of –31, signal that the price is high relative to earnings and book value. The company has no operating revenue, negative cash flow, and a negative book value per share, underscoring the speculative nature of a SPAC awaiting a merger.
Given the extreme greed sentiment (Fear & Greed Index 89.9) and the absence of fundamental earnings, the upside is largely contingent on a successful business combination. The lack of dividends, minimal cash reserves, and high PE suggest limited intrinsic value, while the low beta and volatility mask underlying execution risk. Liquidity constraints and the SPAC’s inherent regulatory scrutiny add layers of uncertainty. Investors should weigh the bullish technical setup against the fundamentally speculative profile before committing capital.
Given the extreme greed sentiment (Fear & Greed Index 89.9) and the absence of fundamental earnings, the upside is largely contingent on a successful business combination. The lack of dividends, minimal cash reserves, and high PE suggest limited intrinsic value, while the low beta and volatility mask underlying execution risk. Liquidity constraints and the SPAC’s inherent regulatory scrutiny add layers of uncertainty. Investors should weigh the bullish technical setup against the fundamentally speculative profile before committing capital.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near resistance with bullish SMA alignment
- Decreasing volume indicating potential short‑term weakness
- Low beta and volatility reduce market‑wide risk
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- High PE and negative price‑to‑book suggest overvaluation
- No operating revenue or positive cash flow
- Liquidity risk due to thin daily trading volume
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Outcome depends on successful merger or acquisition
- Extreme greed sentiment could drive speculative demand
- Fundamental fundamentals remain absent, limiting long‑term upside
Key Metrics & Analysis
Financial Health
P/E Ratio32.2
P/B Ratio-31.1
Op. Cash Flow$-669509
Industry P/E17.7
Technical Analysis
TrendBullish
RSI63.7
Support$10.26
Resistance$10.31
MA 20$10.29
MA 50$10.28
MA 200$10.23
MACDBearish
VolumeDecreasing
Fear & Greed Index89.91
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.02
Volatility1.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.